Goss Wealth Management »

Travere Therapeutics shares owned by Goss Wealth Management

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Goss Wealth Management from 13F filings

Historical chart of Goss Wealth Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Goss Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Goss Wealth Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $30k 21k 1.42

More positions owned by Goss Wealth Management

Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Ishares Core MF Closed and MF Open (IVV)
Amazon Common Stock (AMZN)
Jpmorgan Chase Common Stock (JPM)
Alphabet Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
SPDR S&P MF Closed and MF Open (SPY)
Walmart Common Stock (WMT)
Berkshire Hathaway Common Stock (BRK.B)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Meta Platforms Common Stock (META)
Visa Common Stock (V)

View all positions for Goss Wealth Management

Top funds holding Travere Therapeutics

Linden Advisors
D. E. Shaw & Co
Graham Capital Management
Advent Capital Management
Millennium Management
Lord, Abbett & Co
Point72 Asset Management
Oaktree Capital Management
Agf Management
Polar Capital Holdings
Affinity Asset Advisors
Shenkman Capital Management
Henderson Group
Goldman Sachs Group
FMR

View all funds holding Travere Therapeutics